Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffer from PMS; and one in every twenty women demonstrate life disturbing symptoms. Pre-menstrual dysphoric disorder (PMDD) is a further severe form of PMS and demonstrates more severe symptoms of PMS, often interfering with social activities, work and emotional balance. PMDD occurs in 3% to 5% of menstruating women.
The peptide therapeutic market is expected to grow at a CAGR of 10.5% during the forecast period of 2025 to 2033, propelling its growth, supported by innovative research, increasing prevalence of chronic diseases, and a focus on personalized medicine. Despite challenges related to cost and accessibility, the market exhibits resilience, driven by diverse applications across different segments. The segmentation analysis highlights the varied therapeutic needs and settings where these proteins and peptides find application.
The treatment-resistant depression treatment market is exhibiting good growth at a compounded annual growth rate (CAGR) of 3.6% during the forecast period from 2025 to 2033. Depression is the most common mental disorder affecting approximately 300 million people worldwide.
According to the WHO, nosocomial infection is defined as “an infection acquired in hospital by a patient who was admitted for a reason other than that infection”. An infection occurring in a patient in a hospital or other health care facility in whom the infection was not present or incubating at the time of admission. This includes infections acquired in the hospital but appearing after discharge, and also occupational infections among staff of the facility.
This report on global small animal respiratory diseases treatment market studies various type of diseases, drug class and geography. According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
Patient infotainment terminals are primarily bedside terminals that allow patients to access various multimedia files, play games and make phone calls. In addition, these systems allow Internet access through which patients can check emails, messages and perform regular work functions. Patient infotainment systems can also be connected to the hospital intranet enabling medical staff to easily access patient’s medical information.
Rheumatoid arthritis is an autoimmune, inflammatory disease that causes chronic pain, swelling and loss in the functioning ability of joints. It occurs when the immune system attacks the synovium – the inner lining of membranes that surrounds the joints. In some patients, the antibodies also damage some body systems including the skin, heart, eyes, lungs and blood vessels. Prevalence of rheumatoid arthritis widely varies in different geographic region, the lowest rates is observed in the Asian countries and higher rates among some American populations.
Fabry disease is a rare, X-linked inherited, disorder of lipid metabolism resulting from the deficient activity of the enzyme, alpha-galactosidase-A. This enzyme normally responsible for the breakdown of globotriaosylceramide, results in abnormal deposits of a particular fatty substance in walls of the blood vessel throughout the body. Characteristic features of Fabry disease include episodes of pain, cloudiness of the front part of the eye, clusters of small and dark red spots on the skin, hearing loss also involves life-threatening complications such as heart attack, kidney damage and stroke.
Parkinson’s disease (PD), is progressive nervous system disorders, characterized by tremor, rigidity, bradykinesia, and postural instability. It is estimated that, the global Parkinson’s disease therapeutics market will show significant market growth over the forecast period from 2025 to 2033.
This report titled “Corrugated Box Packaging Market - Growth, Future Prospects, and Competitive Analysis, 2016 – 2025” offers strategic insights into the trends in corrugated box packaging market along with the market size and forecast for the duration 2013 to 2025. The said research study incorporates in-depth analysis of multiple market segments based on application and geographical distribution.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
